eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Mercury

Author: Barry M Diner, MD, MPH, FACEP, Assistant Clinical Professor, Department of Emergency Medicine, Emory University School of Medicine; Attending Physician, St Luke's Episcopal Hospital, Houston, Texas
Coauthor(s): Barry E Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, University Hospitals, Case Medical Center
Contributor Information and Disclosures

Updated: Sep 18, 2009

Introduction

Background

Throughout the centuries, several incidents of mercury toxicity have been reported. Mercury has been found in Egyptian tombs, indicating it was used as early as 1500 BC. In the late 18th century, antisyphilitic agents contained mercury. It was during the 1800s that the phrase "mad as a hatter" was coined because of the chronic mercury exposure that the felters faced because mercury was used in hat making.

In the 1940s and 1950s, mercury became known as the product that caused acrodynia, also known as pink disease. Manifestations of acrodynia include pain and erythema of the palms and soles, irritability, insomnia, anorexia, diaphoresis, photophobia, and rash.

Some of the more recent occurrences include exposures in Minamata Bay in Japan (1960); mercury contaminated fish in Canada; methylmercury-treated grain in Iraq (1960, 1970); and, in the United States (1996), a beauty cream product from Mexico called "Crèma de Belleza-Manning."

For centuries, mercury was an essential part of many different medicines, such as diuretics, antibacterial agents, antiseptics, and laxatives. More recently, these drugs have been substituted and drug-induced signs of mercury toxicity are rare. Mercury toxicity in environmental pollution is a major concern because of increased usage of fossil fuels and agricultural products, both of which contain mercury.

Mercury poisoning is usually misdiagnosed because of the insidious onset, nonspecific signs and symptoms, and lack of knowledge within the medical profession.

Mercury is found in many industries, such as battery, thermometer, and barometer manufacturing. Mercury can be found in fungicides used in the agricultural industry. Before 1990, paints contained mercury as an antimildew agent. In medicine, mercury is used in dental amalgams and various antiseptic agents.

On July 7, 1999, a joint statement by the American Academy of Pediatrics (AAP) and the US Public Health Service (USPHS) was issued alerting clinicians and the public of thimerosal, a mercury-containing preservative used in some vaccines. Subsequent investigation has not proven any definite link between this small amount of mercury and any known disease.

Most recently, 2 areas have caused public concern regarding mercury toxicity: (1) the potential risk associated with eating fish, especially when dealing with pregnancy and (2) the use of dental amalgams, or fillings, by dentists. In May 2001, one of Canada's largest newspapers, the National Post, featured an exposé on the pros and cons of eating fish titled, "One fish, two fish, good fish, bad fish" in its "Health and Medicine" section.

Pathophysiology

Mercury is the only metal that is liquid at room temperature. Its elemental symbol is Hg, which is derived from the Greek word hydrargyrias, meaning "water silver." Mercury is found in organic and inorganic forms. The inorganic form can be further divided into elemental mercury and mercuric salts. Organic mercury can be found in long and short alkyl and aryl compounds.

Mercury in any form is toxic. The difference lies in how it is absorbed, the clinical signs and symptoms, and the response to treatment modalities. Mercury poisoning can result from vapor inhalation, ingestion, injection, or absorption through the skin.

Neurologic, gastrointestinal, and renal systems are the most commonly affected organ systems in mercury exposure.

  • Organic mercury - Most devastating to the CNS
    • Short-chained (methylmercury) - Affects the CNS
    • Long-chained - Subacute/chronic effects similar to that of inorganic mercury exposure
  • Elemental mercury - Primary neurologic toxicity
  • Inorganic mercury salts
    • Acute - Severe corrosive gastroenteritis, acute tubular necrosis
    • Subacute or chronic - GI, neurologic, and renal dysfunction

Elemental mercury (Hg) is found in liquid form, which easily vaporizes at room temperature and is well absorbed (80%) through inhalation. Its lipid-soluble property allows for easy passage through the alveoli into the bloodstream and red blood cells (RBCs). Once inhaled, elemental mercury is mostly converted to an inorganic divalent or mercuric form by catalase in the erythrocytes. This inorganic form has similar properties to inorganic mercury (eg, poor lipid solubility, limited permeability to the blood-brain barrier, and excretion in feces). Small amounts of nonoxidized elemental mercury continue to persist and account for central nervous system toxicity.

Elemental mercury as a vapor has the ability to penetrate the CNS, where it is ionized and trapped, attributing to its significant toxic effects. Elemental mercury is not well absorbed by the GI tract and, therefore, when ingested (eg, thermometers), is only mildly toxic.

Inorganic mercury, found mostly in the mercuric salt form (eg, batteries), is highly toxic and corrosive. It gains access to the body orally or dermally and is absorbed at a rate of 10% of that ingested. It has a nonuniform mode of distribution secondary to poor lipid solubility and accumulates mostly in the kidney, causing significant renal damage. Although poor lipid solubility characteristics limit CNS penetration, slow elimination and chronic exposure allow for significant CNS accumulation of mercuric ions and subsequent toxicity. Long-term dermal exposure to inorganic mercury may also lead to toxicity.

Excretion of inorganic mercury, as with organic mercury, is mostly through feces. Renal excretion of mercury is considered insufficient and attributes to its chronic exposure and accumulation within the brain, causing CNS effects.

Organic mercury can be found in 3 forms, aryl and short- and long-chain alkyl compounds. Organic mercurials are absorbed more completely from the GI tract than inorganic salts are; this is because of intrinsic properties, such as lipid solubility and mild corrosiveness (although much less corrosive than inorganic mercury). Once absorbed, the aryl and long-chain alkyl compounds are converted to their inorganic forms and possess similar toxic properties to inorganic mercury. The short-chain alkyl mercurials are readily absorbed in the GI tract (90-95%) and remain stable in their initial forms. Alkyl organic mercury has high lipid solubility and is distributed uniformly throughout the body, accumulating in the brain, kidney, liver, hair, and skin. Organic mercurials also cross the blood-brain barrier and placenta and penetrate erythrocytes, attributing to neurological symptoms, teratogenic effects, and high blood to plasma ratio, respectively.

Methylmercury has a high affinity for sulfhydryl groups, which attributes to its effect on enzyme dysfunction. One enzyme that is inhibited is choline acetyl transferase, which is involved in the final step of acetylcholine production. This inhibition may lead to acetylcholine deficiency, contributing to the signs and symptoms of motor dysfunction.

Excretion of alkyl mercury occurs mostly in the form of feces (90%), secondary to significant enterohepatic circulation. The biological half-life of methylmercury is approximately 65 days. Organic mercury is found most commonly in antiseptics, fungicides, and industrial run-off.

Frequency

United States

The 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System documented about 2400 single exposures to mercury or compounds containing mercury.1 Of these, 305 were in children younger than 6 years and 983 were in persons older than 19 years. Overall, 45 individuals were reported to have moderate effects, 3 had major effects, and none died as a result of mercury exposure.

Mortality/Morbidity

Long-term neurologic effects are a major concern with chronic mercury exposure. Three widely publicized topics of concern to the general population are dental fillings, or amalgams, and fish consumption, especially in children and pregnant women, and vaccines

After an exhaustive investigation and review of the evidence, including the form of mercury in question, the route of exposure, and the dose, the Public Health Service concluded that dental amalgams do not pose a serious health risk.2

The primary source of environmental exposure to mercury in the general population is through the consumption of contaminated fish.3 Fish consumption has clear health benefits, and the risk posed by mercury exposure is currently speculative. The fetal brain is more susceptible to mercury-induced damage than that of an adult. As a result of this data, the Environmental Protection Agency (EPA) reduced the allowable intake of methylmercury from 0.5 mcg to 0.1 mcg of mercury per kilogram per day, which is lower than the amount allowable according to other regulatory agencies.4 The EPA guideline is derived from reports of subtle and small neuropsychologic changes in children in the Faeroe Islands study, whose exposure was mainly from whale consumption.5 A similar study in the Seychelles found no adverse effects from fish consumption alone.6

The Food and Drug Administration (FDA) has recommended that pregnant women, breastfeeding mothers, and young children avoid eating fish with a high mercury content (>1 ppm), such as shark, swordfish, tilefish, and king mackerel. This also includes fresh and frozen tuna (mercury content between 0.5 ppm and 1.5 ppm) but not canned tuna, which consists of smaller, shorter-lived species with lower mercury levels. From a nonprofessional perspective, this translates into a weekly consumption of one can (198 g or 7 oz) of tuna for an adult.7 Rather than ban the sale of these species, Health Canada recommends that they be consumed no more than once per week or once per month by children and by women of childbearing age.8 Mercury levels in freshwater fish vary, but, in general, bass, pike, muskellunge, and walleye have high levels of mercury and should be eaten in moderation. Provincial guidelines for sport fish often mirror federal seafood recommendations.9

Thimerosal is a mercury-containing preservative used in some vaccines and other products since the 1930s. No harmful effects have been reported from thimerosal at doses used in vaccines, except for minor reactions like redness and swelling at the injection site. However, in July 1999, the Public Health Service (PHS) agencies, the American Academy of Pediatrics (AAP), and vaccine manufacturers agreed that thimerosal should be reduced or eliminated in vaccines as a precautionary measure. Today, with the exception of some influenza vaccines, none of the vaccines used in the United States to protect preschool children against 12 infectious diseases contain thimerosal as a preservative.10

In 2004, Immunization Safety Review Committee of the IOM shifted from the position of neutrality to the conclusion that "the evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism."11  Since 2004, two cohort studies from the United Kingdom examined the relationship between thimerosal contained within vaccines and autism, and their conclusions were in agreement with the IOM that there is no casual relationship between the two.

Race

No scientific evidence has demonstrated any difference in the outcome of mercury exposure that is attributable to race.

Sex

No scientific evidence has demonstrated any difference in the outcome of mercury exposure that is attributable to sex.

Clinical

History

The diagnostic approach for patients with suspected mercury toxicity begins with a thorough history that includes occupations, hobbies, and levels of seafood intake. All toxic presentations, whether acute, chronic, or subacute, are difficult diagnoses because multiple organ systems are affected (eg, CNS, kidney, mucous membranes) and can mimic a variety of other diseases. If no such history exists, clinical suspicion can be confirmed by laboratory analysis.

The clinical presentation of mercury toxicity can manifest in a variety of ways, depending on the nature of the exposure, the intensity of the exposure, and the chemical form. Acute toxicity usually is related to the inhalation of elemental mercury or ingestion of inorganic mercury. Exposure to organic mercury leads to chronic toxicity and, occasionally, acute toxicity.
 

Palm of a patient showing discrete erythematous p...

Palm of a patient showing discrete erythematous papules and papulovesicles. Note lack of oozing, crusts, or excoriations. Although there is some increased palmar erythema, it differs from pink disease of inorganic mercury poisoning of children by presence of papules and lack of pain. Image Courtesy of American Academy of Dermatology.

Palm of a patient showing discrete erythematous p...

Palm of a patient showing discrete erythematous papules and papulovesicles. Note lack of oozing, crusts, or excoriations. Although there is some increased palmar erythema, it differs from pink disease of inorganic mercury poisoning of children by presence of papules and lack of pain. Image Courtesy of American Academy of Dermatology.


Arm of a patient showing discrete scattered (shot...

Arm of a patient showing discrete scattered (shotgun) 1- to 2-mm papules. Note lack of oozing, crusts, excoriations, or other signs of acute eczema. Image Courtesy of American Academy of Dermatology.

Arm of a patient showing discrete scattered (shot...

Arm of a patient showing discrete scattered (shotgun) 1- to 2-mm papules. Note lack of oozing, crusts, excoriations, or other signs of acute eczema. Image Courtesy of American Academy of Dermatology.

  • Acute exposure caused by inhaled elemental mercury can lead to pulmonary symptoms. Initial signs and symptoms, such as fever, chills, shortness of breath, metallic taste, and pleuritic chest pain, may be confused with metal fume fever. Other possible symptoms could include stomatitis, lethargy, confusion, and vomiting. In addition, elemental mercury can also be injected causing a life-threatening pulmonary embolism.
  • Recovery is usually without sequela, but pulmonary complications of inhaled toxicity may include interstitial emphysema, pneumatocele, pneumothorax, pneumomediastinum, and interstitial fibrosis. Fatal ARDS has been reported following elemental mercury inhalation.
  • Chronic and intense acute exposure causes cutaneous and neurological symptoms. The classic triad found in chronic toxicity is tremors, gingivitis, and erethism (ie, a constellation of neuropsychiatric findings that includes insomnia, shyness, memory loss, emotional instability, depression, anorexia, vasomotor disturbance, uncontrolled perspiration, and blushing).
  • Additional findings may include headache, visual disturbance (eg, tunnel vision), peripheral neuropathy, salivation, insomnia, and ataxia.
  • Without a complete history, mercury toxicity, especially in elderly individuals, can be misdiagnosed as Parkinson disease, senile dementia, metabolic encephalopathy, depression, or Alzheimer disease.
  • Elemental mercury has poor GI absorption and, therefore, oral or rectal exposure to elemental mercury from a thermometer should have no toxic effect. Dental amalgams also contain elemental mercury. Dental professionals who are in contact with amalgam must follow specific guidelines to avoid exposure to toxic amounts of aerosolized elemental mercury. Patients with dental amalgam fillings have slightly elevated levels in their urine, but these findings have not correlated with any systemic disease.
    • In December 2002, the United States Food and Drug Administration (FDA) published a Consumer Update on dental amalgams. It had the following statement to make: "FDA and other organisations of the U.S. Public Health SERVICE (USPHS) * continue to investigate the safety of amalgams used in dental restorations (fillings). However, no valid scientific evidence has shown that amalgams cause harm to patients with dental restorations, except in the rare case of allergy".12
    • The FDA has now released final regulations on the use of dental amalgam.13
  • Inorganic mercury or mercuric salt exposure mainly occurs through the oral and GI tract. Its corrosive properties account for most of the acute signs and symptoms of inorganic mercury or mercuric salt toxicity. The acute presentation can include ashen-gray mucous membranes secondary to precipitation of mercuric salts, hematochezia, vomiting, severe abdominal pain, and hypovolemic shock. Systemic effects usually begin several hours postingestion and may last several days. These effects include metallic taste, stomatitis, gingival irritation, foul breath, loosening of teeth, and renal tubular necrosis leading to oliguria or anuria.
  • Batteries contain inorganic mercury but are rarely the cause of systemic symptoms. Ingestion of batteries by pediatric patients is a common problem, and its complications are related to local corrosive complications.
    • Consider chelation therapy in patients who ingest mercury-containing batteries if symptoms of mercury toxicity are present.
    • Use of cathartics and water-soluble enemas is useful for increasing transit time of released mercury, but these treatments are not indicated for intact batteries.
  • Chronic exposure usually results from prolonged occupational exposure to elemental mercury that is converted into the inorganic form, topical application of mercurial salves, and the chronic use of diuretics or cathartics.
    • Chronic exposure can present with renal failure, dementia, and acrodynia.
    • Acrodynia, known as Pink disease and considered to be a mercury allergy, presents with erythema of the palms and soles, edema of the hands and feet, desquamating rash, hair loss, pruritus, diaphoresis, tachycardia, hypertension, photophobia, irritability, anorexia, insomnia, poor muscle tone, and constipation or diarrhea.
    • Acrodynia does not present in everyone who is exposed to inorganic mercury, but it is an indicator of widespread disease.
  • Organic mercury poisoning usually results from ingestion of contaminated food. The long chain and aryl forms of organic mercury have similar characteristics of inorganic mercury toxicity.
    • The onset of symptoms usually is delayed (days to weeks) after exposure.
    • Organic mercury targets enzymes, and the depletion of these enzymes must occur before the onset of symptoms.
    • Symptoms related to toxicity are typically neurological, such as visual disturbance (eg, scotomata, visual field constriction), ataxia, paresthesias (early signs), hearing loss, dysarthria, mental deterioration, muscle tremor, movement disorders, and, with severe exposure, paralysis, and death.
    • Organic mercury targets specific sites in the brain, including the cerebral cortex (especially visual cortex), motor and sensory centers (precentral and postcentral cortex), auditory center (temporal cortex), and cerebellum.
  • All forms of mercury are toxic to the fetus, but methylmercury most readily passes through the placenta. Even with an asymptomatic patient, maternal exposure can lead to spontaneous abortion or retardation.

Physical

Focus the physical examination on the areas most commonly affected.

  • Perform a complete neurological examination, including a detailed cerebellar examination. Perform a full visual field evaluation.
  • Perform abdominal and rectal examinations, with stool guaiac testing, and include documentation of a skin examination.

Causes

  • Causes of elemental mercury toxicity include barometers, batteries, bronzing, calibration instruments, chlor-alkali production, dental amalgams, electroplating, fingerprinting products, fluorescent and mercury lamps, infrared detectors, the jewelry industry, manometers, neon lamps, paints, paper pulp production, photography, silver and gold production, semiconductor cells, and thermometers.
  • The causes of inorganic mercury toxicity include antisyphilitic agents, acetaldehyde production, chemical laboratory work, cosmetics, disinfectants, explosives, embalming, fur hat processing, ink manufacturing, mercury vapor lamps, mirror silvering, the perfume industry, photography, spermicidal jellies, tattooing inks, taxidermy production, vinyl chloride production, and wood preservation.
  • The causes of organic mercury toxicity include antiseptics, bactericidals, embalming agents, the farming industry, fungicides, germicidal agents, insecticidal products, laundry products, diaper products, paper manufacturing, pathology products, histology products, seed preservation, and wood preservatives.
  • Very contraversial source of organic mercury exposure is thimerosal, an additive preservative used in vaccines to prevent bacterial contamination. The most commonly used vaccines that contain thimerosal are for diphtheria-tetanus-whole cell pertussis (DTP), Haemophilus influenzae (HIB), and hepatitis B.

More on Toxicity, Mercury

Overview: Toxicity, Mercury
Differential Diagnoses & Workup: Toxicity, Mercury
Treatment & Medication: Toxicity, Mercury
Follow-up: Toxicity, Mercury
Multimedia: Toxicity, Mercury
References

References

  1. Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila). Dec 2008;46(10):927-1057. [Medline].

  2. Public Health Service. Dental amalgam: a scientific review and recommended Public Health Service strategy for research, education, and regulation. Public Health Service. January 1993;[Full Text].

  3. ATSDR. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Mercury. ATSDR. August 1997.

  4. EPA. Water quality criterion for the protection of human health: methylmercury. Environmental Protection Agency. Jan 2001;EPA-823-R-01-001.

  5. CDC. From the Centers for Disease Control and Prevention. Blood and hair mercury levels in young children and women of childbearing age--United States, 1999. JAMA. Mar 21 2001;285(11):1436-7. [Medline].

  6. Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet. May 17 2003;361(9370):1686-92. [Medline].

  7. Canadian Food Inspection Agency. Food safety facts on mercury and fish consumption. Canadian Food Inspection Agency. Available at http://www.inspection.gc.ca/english/fssa/concen/specif/mercurye.shtml. Accessed May 2002.

  8. Health Canada. Advisory: Information on mercury levels in fish. May 29, 2002. Health Canada Online. Available at http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2002/2002_41_e.html.

  9. Ontario Ministry of the Environment. Guide to eating Ontario sport fish, 2001-2002. 21st ed rev. Ontario Ministry of the Environment. 2001.

  10. Centers for Disease Control and Prevention. Mercury and Vaccines (Thimerosal). Updated June 2007. Available at http://www.cdc.gov/od/science/iso/concerns/thimerosal.htm.

  11. World Health Organization. World Health Organization: Global Advisory Committee on Vaccine Safety. Rec 32. WHO; 2003 Jun 11–12. 282-284.

  12. Food and Drug Administration. Consumer Update on dental amalgams. United States Food and Drug Administration (FDA). Available at http://www.fda.gov/. Accessed March 30, 2009.

  13. FDA Issues Final Regulation on Dental Amalgam. July 28, 2009. FDA News Release. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm173992.htm.

  14. Belson MG, Schier JG, Patel MM; CDC. Case definitions for chemical poisoning. MMWR Recomm Rep. Jan 14 2005;54(RR-1):1-24. [Medline].

  15. Ruedy J. Methylmercury poisoning. CMAJ. Oct 30 2001;165(9):1193-4. [Medline].

  16. Young-Jin S. Mercury. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, et al, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York: The McGraw-Hill Companies; 2006:96.

  17. [Guideline] Charlton N, Wallace KL. American College of Medical Toxicology - Position Statement: Post-Chelator Challenge Urinary Metal Testing. July 27, 2009. [Full Text].

  18. Environmental Protection Agency (EPA). Spills, Disposal and Site Cleanup. US Environmental Protection Agency. Available at http://www.epa.gov/mercury/spills/index.htm. Accessed March 30, 2009.

  19. Abramson, JS. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health. Pediatrics. Sep 1999;104(3 Pt 1):570-4. [Medline].

  20. Bates B. Heavy metals and inorganic agents. In: Clinical Management of Poisoning and Drug Overdose. Vol 55. WB Saunders; 1998:750-6.

  21. Clifton JC 2nd. Mercury exposure and public health. Pediatr Clin North Am. Apr 2007;54(2):237-69, viii. [Medline].

  22. Ford M. Heavy metals. In: Tintinalli JE, ed. Emergency Medicine: A Comprehensive Study Guide. Vol 158. 4th ed. McGraw-Hill; 1996:839-41.

  23. Goyer RA. Toxic effects of metals. In: Casarett LJ, ed. Casarett and Doull's Toxicology: The Basic Science of Poisons. 5th ed. New York: McGraw-Hill; 1996:709-713.

  24. Graeme KA, Pollack CV Jr. Heavy metal toxicity, Part I: arsenic and mercury. J Emerg Med. Jan-Feb 1998;16(1):45-56. [Medline].

  25. Heron J, Golding J, ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association. Pediatrics. Sep 2004;114(3):577-83. [Medline].

  26. Kershaw TG, Clarkson TW, Dhahir PH. The relationship between blood levels and dose of methylmercury in man. Arch Environ Health. Jan-Feb 1980;35(1):28-36. [Medline].

  27. Klaassen C. Heavy metals and heavy metal antagonists. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; 1996:1654-1659.

  28. Norseth T, Clarkson TW. Studies on the biotransformation of 203Hg-labeled methyl mercury chloride in rats. Arch Environ Health. Dec 1970;21(6):717-27. [Medline].

  29. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics. Sep 2004;114(3):793-804. [Medline].

  30. Poddar AS, Kim JG, Gill KP, et al. Generation and characterization of a polyclonal antipeptide antibody to human glycodelin. Fertil Steril. Mar 1998;69(3):543-8. [Medline].

  31. Taueg C, Sanfilippo DJ, Rowens B, et al. Acute and chronic poisoning from residential exposures to elemental mercury--Michigan, 1989-1990. J Toxicol Clin Toxicol. 1992;30(1):63-7. [Medline].

  32. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2004;22(5):335-404. [Medline].

  33. Young J. Mercury. In: Goldfrank LR, ed. Goldfrank's Toxicology Emergencies. Vol 74. New York: McGraw-Hill; 1994:1051-62.

Further Reading

Keywords

Hg, heavy metal, mercury poisoning, mercury salts, methyl mercury, methylmercury, acrodynia, pink disease, acrodynic erythema, dermatopolyneuritis, erythredema, Swift disease, Swift's disease, hydrargyria, hydrargyrism, mercurialism, acute mercury poisoning, chronic mercury poisoning, inorganic mercury exposure, organic mercury exposure, elemental mercury exposure, inorganic mercury salt exposure, mercury toxicity, mercury ingestion, thimerosal

Contributor Information and Disclosures

Author

Barry M Diner, MD, MPH, FACEP, Assistant Clinical Professor, Department of Emergency Medicine, Emory University School of Medicine; Attending Physician, St Luke's Episcopal Hospital, Houston, Texas
Barry M Diner, MD, MPH, FACEP is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Canadian Association of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Barry E Brenner, MD, PhD, FACEP, Professor of Emergency Medicine, Professor of Internal Medicine, Program Director, Emergency Medicine, University Hospitals, Case Medical Center
Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Michelle Ervin, MD, Chair, Department of Emergency Medicine, Howard University Hospital
Michelle Ervin, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, National Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart & St. Joseph's Hospitals
John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Fred Harchelroad, MD, FACMT, FAAEM, FACEP, Chair, Department of Emergency Medicine, Director of Medical Toxicology - Allegheny General Hospital, Associate Professor, Department of Emergency Medicine, Drexel University College of Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.